Cargando…
Rapid characterization of spike variants via mammalian cell surface display
The SARS-CoV-2 spike protein is a critical component of vaccines and a target for neutralizing monoclonal antibodies (nAbs). Spike is also undergoing immunogenic selection with variants that increase infectivity and partially escape convalescent plasma. Here, we describe Spike Display, a high-throug...
Autores principales: | Javanmardi, Kamyab, Chou, Chia-Wei, Terrace, Cynthia I., Annapareddy, Ankur, Kaoud, Tamer S., Guo, Qingqing, Lutgens, Josh, Zorkic, Hayley, Horton, Andrew P., Gardner, Elizabeth C., Nguyen, Giaochau, Boutz, Daniel R., Goike, Jule, Voss, William N., Kuo, Hung-Che, Dalby, Kevin N., Gollihar, Jimmy D., Finkelstein, Ilya J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675084/ https://www.ncbi.nlm.nih.gov/pubmed/34919820 http://dx.doi.org/10.1016/j.molcel.2021.11.024 |
Ejemplares similares
-
Antibody escape and cryptic cross-domain stabilization in the SARS-CoV-2 Omicron spike protein
por: Javanmardi, Kamyab, et al.
Publicado: (2022) -
Molecular Architecture of Early Dissemination and Massive Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area
por: Long, S. Wesley, et al.
Publicado: (2020) -
Molecular Architecture of Early Dissemination and Massive Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area
por: Long, S. Wesley, et al.
Publicado: (2020) -
Synthetic repertoires derived from convalescent COVID-19 patients enable discovery of SARS-CoV-2 neutralizing antibodies and a novel quaternary binding modality
por: Goike, Jule, et al.
Publicado: (2021) -
Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes
por: Voss, William N., et al.
Publicado: (2021)